Capital Fund Management S.A. Sells 116,116 Shares of Doximity, Inc. (NASDAQ:DOCS)

Capital Fund Management S.A. lessened its position in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 86.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 18,055 shares of the company's stock after selling 116,116 shares during the period. Capital Fund Management S.A.'s holdings in Doximity were worth $964,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Morse Asset Management Inc acquired a new stake in shares of Doximity during the third quarter worth approximately $46,000. Orion Portfolio Solutions LLC acquired a new position in Doximity in the third quarter valued at approximately $260,000. Barclays PLC grew its holdings in Doximity by 60.5% during the 3rd quarter. Barclays PLC now owns 53,401 shares of the company's stock worth $2,327,000 after acquiring an additional 20,125 shares during the period. M&T Bank Corp bought a new stake in shares of Doximity during the 3rd quarter valued at $351,000. Finally, Geode Capital Management LLC boosted its position in shares of Doximity by 19.8% in the 3rd quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company's stock worth $124,503,000 after purchasing an additional 472,565 shares during the last quarter. Institutional investors and hedge funds own 87.19% of the company's stock.

Doximity Stock Up 0.6 %

NASDAQ:DOCS traded up $0.32 on Friday, hitting $53.10. The stock had a trading volume of 1,941,624 shares, compared to its average volume of 1,985,039. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $85.21. The business's fifty day moving average is $62.97 and its 200 day moving average is $55.83. The company has a market cap of $9.91 billion, a PE ratio of 53.10, a P/E/G ratio of 4.10 and a beta of 1.41.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. The Goldman Sachs Group upped their price target on Doximity from $58.00 to $80.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Bank of America increased their price objective on shares of Doximity from $54.00 to $57.00 and gave the stock a "neutral" rating in a research report on Monday, January 6th. Truist Financial dropped their target price on Doximity from $65.00 to $58.00 and set a "hold" rating on the stock in a research report on Thursday, April 10th. Canaccord Genuity Group raised their price objective on Doximity from $60.00 to $71.00 and gave the company a "hold" rating in a report on Friday, February 7th. Finally, KeyCorp cut their price objective on Doximity from $83.00 to $70.00 and set an "overweight" rating for the company in a report on Wednesday. Eleven investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $65.00.

Insider Buying and Selling

In related news, Director Timothy S. Cabral sold 20,000 shares of the company's stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the sale, the director now owns 6,360 shares in the company, valued at approximately $366,463.20. This represents a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 37.40% of the stock is owned by company insiders.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.